Non-dystrophic myotonias and periodic paralyses A European Neuromuscular Center Workshop held 4–6 October 1992, Ulm, Germany

  title={Non-dystrophic myotonias and periodic paralyses A European Neuromuscular Center Workshop held 4–6 October 1992, Ulm, Germany},
  author={Frank Lehmann-Horn and Reinhardt Rüdel and Kenneth Ricker},
  journal={Neuromuscular Disorders},

Figures and Tables from this paper

A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes

A clinical and genetic study of the skeletal muscle channelopathies

The first cases of large scale rearrangements in CLCN1 causing myotonia congenita are described and the genetic diagnosis rate can be improved, and two cases that may be explained by variations in RYR1 are illustrated.

Mutations in the Muscle Sodium Channel Gene (SCN4A) in 13 French Families with Hyperkalemic Periodic Paralysis and Paramyotonia Congenita: Phenotype to Genotype Correlations and Demonstration of the Predominance of Two Mutations

Recurrent mutations of SCN4A may contribute to the predominance of these two mutations in the French population by contributing to the severity of myotonia and its permanence were variable.

Channelopathies of skeletal muscle excitability.

A synthesis of the mechanistic connections between functional defects of mutant ion channels, their impact on muscle excitability, how these changes cause clinical phenotypes, and approaches toward therapeutics is provided.

Identification of three novel mutations in the major human skeletal muscle chloride channel gene (CLCN1), causing myotonia congenita

Three novel and one known mutations of the CLCN1 gene are reported in four unrelated MC families, reducing the proportion of MC patients in whom genetic alterations have not been found.



Sodium channel mutations in acetazolamide‐responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis

This report summarizes the sodium channel mutation analysis in 25 families with hyperKPP and reports the putative disease-causing mutation in acetazolamide-responsiveMyotonia congenita, a related disease in which myotonia is worsened by potassium but in which episodic weakness does not occur.

Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III‐IV linker.

Electrophysiological and molecular genetic studies strongly suggest that three dominant point mutations discovered at the same nucleotide position of the SCN4A gene encoding the adult skeletal muscle Na+ channel alpha‐subunit cause myotonia.

Myotonia fluctuans. A third type of muscle sodium channel disease.

The findings in the present report indicate that myotonia fluctuans belongs to a third type of sodium channel disorder, and further work is needed to understand the complex genotype-phenotype correlations in sodium channel disorders.

Adynamia episodica hereditaria with myotonia: A non‐inactivating sodium current and the effect of extracellular pH

Lowering of the extracellular pH did not influence the resting potential, but it effectively antagonized or prevented the paralytic effect of high [K]e by changing the inactivation characteristics of the sodium channels.

A Met-to-Val mutation in the skeletal muscle Na+ channel α-subunit in hyperkalaemic periodic paralysis

An A - G substitution in the patient's messenger RNA that causes a Met-Val change in a highly conserved region of the α-subunit, predicted to be in a transmembrane domain is identified and discovered a voltage-gated channel mutation responsible for a human genetic disease.

The skeletal muscle chloride channel in dominant and recessive human myotonia.

An unusual restriction site in the CLC-1 locus in two GM families identified a mutation associated with that disease, a phenylalanine-to-cysteine substitution in putative transmembrane domain D8, which suggests that different mutations in C LC-1 may cause dominant or recessive myotonia.

Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker)

The electrical instability of the membrane and the transient weakness can be explained on the basis of the N‐shaped membrane characteristic.

Familial periodic paralysis with hypokalaemia. Study of a muscle biopsy in the myopathic stage of the disorder.

Key findings in this case are the sequence of events leading to muscle fibre destruction, still detectable at an advanced stage of the disease and myopathic changes represent a delayed but severe complication of the disorder.